Bill Texts: US HB4242 | 2023-2024 | 118th Congress

Bill Title: To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to issue guidance on considerations for conducting clinical trials for psychedelic assisted therapy.

Spectrum: Slight Partisan Bill (Republican 2-1)

Status: (Introduced) 2023-06-23 - Referred to the Subcommittee on Health. [HB4242 Detail]

Bill Drafts

RevisionDateFormatSourceView
Introduced2023-07-29PDFLinkView

Amendments

AmendmentDateDispositionFormatSourceView
No bill amendments currently on file for US Congress HB4242

Supplemental Documents

TitleDescriptionDateFormatSourceView
No supplemental documents for US Congress HB4242 currently on file.

Social Comments on US HB4242

feedback